Key result
Novel aldosterone-to-renin immunoassay detects primary aldosteronism with ~92% sensitivity.
Observational (n=222)
Answers are grounded in this paper and cite their sources.
Demonstrates rapid automated simultaneous measurement of aldosterone and renin in hypertensive individuals, suggesting a faster alternative for primary aldosteronism screening.
Measurement of plasma aldosterone and renin concentration, or activity, is useful for selecting antihypertensive agents and detecting hyperaldosteronism in hypertensive patients. However, it takes several days to get results when measured by radioimmunoassay and development of more rapid assays has been long expected. We have developed chemiluminescent enzyme immunoassays enabling the simultaneous measurement of both aldosterone and renin concentrations in 10 minutes by a fully automated assay using antibody-immobilized magnetic particles with quick aggregation and dispersion. We performed clinical validation of diagnostic ability of this newly developed assay-based screening of 125 patients with primary aldosteronism from 97 patients with essential hypertension. Results of this novel assay significantly correlated with the results of radioimmunoassay (aldosterone, active renin concentration, and renin activity) and liquid chromatography-tandem mass spectrometry (aldosterone). The analytic sensitivity of this particularly novel active renin assay was 0.1 pg/mL, which was better than that of radioimmunoassay (2.0 pg/mL). The ratio of aldosterone-to-renin concentrations of 6.0 (ng/dL per pg/mL) provided 92.0% sensitivity and 76.3% specificity as a cutoff for differentiating primary aldosteronism from essential hypertension. This novel measurement is expected to be a clinically reliable alternative for conventional radioimmunoassay and to provide better throughput and cost effectiveness in diagnosis of hyperaldosteronism from larger numbers of hypertensive patients in clinical settings.
No takes yet. Share an insight, caveat, or question.
Morimoto et al. (2017) conducted an observational in Primary aldosteronism and essential hypertension (n=222). Chemiluminescent enzyme immunoassay for simultaneous measurement of plasma aldosterone and active renin concentrations vs. Conventional radioimmunoassay and liquid chromatography-tandem mass spectrometry was evaluated on Diagnostic accuracy for differentiating primary aldosteronism from essential hypertension using an aldosterone-to-renin concentration ratio cutoff of 6.0 (ng/dL per pg/mL). A novel chemiluminescent enzyme immunoassay using an aldosterone-to-renin ratio cutoff of 6.0 achieved 92.0% sensitivity and 76.3% specificity for detecting primary aldosteronism.
Synapse has enriched 10 related papers. Consider them for comparative context: